Introduction
============

Cell adhesion molecules (CAMs) are expressed across all cell types. In the nervous system, multiple families of CAMs are expressed in neurons, including integrins, cadherins, selectins, neuroligins, neurexins, and the immunoglobulin superfamily (IgSF) of CAMs ([@B11]; [@B20]; [@B13]; [@B130]; [@B131]). These molecules play numerous roles in the developing and mature nervous system by regulating growth and branching of neurites, navigating growing axons and dendrites to the appropriate targets, regulating formation and maturation of synaptic contacts, and maintaining synapse function and plasticity during learning and memory formation.

Typically, and for some families exclusively, CAMs are transmembrane proteins. While the extracellular domains of these molecules mediate interactions not only between neurons but also between neurons and other cells by interacting with the same molecules or other types of molecules either on the membranes of other cells or in the extracellular matrix, the intracellular domains are involved in interactions with the cytoskeleton and signal transduction ([@B62]). However, CAMs can also be anchored to the plasma membranes via a glycosylphosphatidylinositol (GPI) anchor, with the highest number of the GPI-anchored CAMs within the IgSF (**Figure [1](#F1){ref-type="fig"}** and **Table [1](#T1){ref-type="table"}**). Although these proteins do not possess intracellular domains, their functions are not limited to mediating cell adhesion only. In this review, we summarize the role GPI-anchored IgSF CAMs have as signal transducers, ligands, synapse formation regulators, as well as their role in synaptic plasticity and brain disorders.

![Examples of the GPI-anchored IgSF CAMs. Structural domains and putative glycosylation sites in the GPI-anchored IgSF CAMs are represented according to the Uniprot database. SS, disulfide bridges present in Ig domains.](fnmol-10-00378-g001){#F1}

###### 

List of the GPI-anchored IgSF CAMs and their functions in neurite outgrowth and synapse formation and plasticity.

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  IgSF member         Number and type of Ig domains                           Homophilic interaction                                   Examples of heterophilic binding partners                                                                                                                                                                         Function in neurite outgrowth as a receptor                                                                         Function in neurite outgrowth as a ligand                                                                         Role in synapse formation                Changes in LTP/LTD in knock-out (KO) or transgenic (TG) mice
  ------------------- ------------------------------------------------------- -------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------- ---------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------
  **CEACAM5**/\       One V-type and six C2-type domains ([@B94]).            In *trans* ([@B153]; [@B132]).                           *Trans* -- NA;*Cis* -- NA;*ECM* -- NA.                                                                                                                                                                            NA                                                                                                                  NA                                                                                                                NA                                       NA
  CD66e/CEA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  **CEACAM6**/\       One V-type and two C2-type domains ([@B94]).            NA                                                       *Trans* -- CEACAM8 ([@B95]);*Cis* -- NA;*ECM* -- NA.                                                                                                                                                              NA                                                                                                                  NA                                                                                                                NA                                       NA
  CD66c/NCA                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  **CEACAM7**/\       One V-type and one C2-type domains ([@B94]).            NA                                                       *Trans* -- NA; *Cis* -- NA;*ECM* -- NA.                                                                                                                                                                           NA                                                                                                                  NA                                                                                                                NA                                       NA
  CGM2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  **CEACAM8**/\       One V-type and two C2-type domains ([@B94]).            NA                                                       *Trans* -- CEACAM6 ([@B95]);*Cis* -- NA;*ECM* -- NA.                                                                                                                                                              NA                                                                                                                  NA                                                                                                                NA                                       NA
  CD66b/CGM6                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            

  **Contactin1** /\   Six C2-type domains ([@B114]; [@B10]).                  NA                                                       *Trans* -- NrCAM, NgCAM ([@B83]); -- PTPRZ ([@B101]; [@B8]); -- CASPR2 ([@B117]); -- Notch ([@B48]). *Cis* -- CASPR ([@B102]); -- L1 ([@B96]). *ECM* -- Chondroitin sulfate E ([@B80]); -- Tenascin-R ([@B90]).   -- Promotes ([@B80]); -- Promotes filopodia and lamellipodia ([@B152]).                                             -- Promotes ([@B137]).                                                                                            NA                                       KO: -- LTP in CA1 is normal, -- LTD in CA1 is impaired ([@B85]); TG (overexpressing): -- LTP in CA1 is normal at 5 months, increased at 12 months of age ([@B109]).
  F3/F11/ Contactin                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

  **Contactin2**/\    Six C2-type domains (but see text) ([@B155]; [@B27]).   in *trans* ([@B112]; [@B25]; [@B73]; [@B69]; [@B136]).   *Trans* --NrCAM ([@B69]); -- NgCAM ([@B26]); -- L1 ([@B58]; [@B126]; [@B25]; [@B142]); -- β1 integrin ([@B25]); -- APP ([@B70]). *Cis* -- L1 ([@B73]); -- NgCAM ([@B12]); -- CASPR2 ([@B136]). *ECM* -- NA.       -- Promotes ([@B12]; [@B69]).                                                                                       -- Promotes ([@B58]; [@B126]; [@B53]).                                                                            NA                                       NA
  Tag1/axonin1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  **Contactin3**/\    Six C2-type domains ([@B149]).                          NA                                                       *Trans* -- PTPRG ([@B8]). *Cis* -- PTPRG ([@B8]; [@B89]). *ECM* -- NA.                                                                                                                                            NA                                                                                                                  -- Promotes ([@B149]).                                                                                            NA                                       NA
  BIG-1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  **Contactin4**/\    Six C2-type domains ([@B148]).                          NA                                                       *Trans* -- PTPRG ([@B8]). *Cis* -- PTPRG ([@B8]). *Soluble* -- NA.                                                                                                                                                NA                                                                                                                  -- Promotes ([@B148])                                                                                             NA                                       NA
  BIG-2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 

  **Contactin5**/\    Six C2-type domains ([@B93])                            NA                                                       *Trans* -- PTPRG ([@B8]). *Cis* -- PTPRG ([@B8]); -- APLP1 ([@B122]). *ECM* -- NA.                                                                                                                                NA                                                                                                                  -- Promotes ([@B8]; [@B78]).                                                                                      NA                                       NA
  NB-2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  **Contactin6**/\    Six C2-type domains ([@B93]).                           NA                                                       *Trans* -- PTPRG ([@B8]). *Cis* -- PTPRG ([@B8]); -- CHL1 ([@B147]). *ECM* -- NA.                                                                                                                                 NA                                                                                                                  -- Promotes ([@B8]; [@B78]).                                                                                      NA                                       NA
  NB-3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

  **IgLON5**          NA                                                      NA                                                       *Trans* -- NA;*Cis* -- NA;*ECM* -- NA.                                                                                                                                                                            NA                                                                                                                  NA                                                                                                                NA                                       NA

  **LAMP**/\          Three C2-type domains ([@B103]).                        in *trans* ([@B154]; [@B67]; [@B36]).                    *Trans* -- Ntm ([@B36]). *Cis* -- OBCAM ([@B115]). *ECM* -- NA.                                                                                                                                                   -- Promotes ([@B23]).                                                                                               -- Promotes via the first Ig-like domain ([@B23]; [@B119]); -- Inhibits via the second Ig-like domain ([@B23]).   -- Promotes ([@B41]).                    KO: -- LTP in CA1 is decreased ([@B110]).
  LSAMP/IGLON3                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  **NEGR1**/\         Three C2-type domains ([@B30]).                         in *trans* ([@B81]) But see, ([@B76]).                   *Trans* -- Ntm, LAMP ([@B76]); -- FGFR2 ([@B104]); -- ObCAM ([@B81]). *Cis* -- NA; *ECM --* NA.                                                                                                                   NA                                                                                                                  -- Promotes ([@B104]; [@B119]).                                                                                   -- Inhibits ([@B41]).                    NA
  Klion/IGLON4                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  **Ntm**/\           Three C2-type domains ([@B129]).                        in *trans* ([@B67]).                                     Trans -- LAMP ([@B36]) *Cis* -- NA; *ECM --* NA.                                                                                                                                                                  -- Promotes ([@B35], [@B36]).                                                                                       -- Promotes ([@B119]).                                                                                            NA                                       NA
  NT/IGLON2                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             

  **OBCAM**/\         Three C2-type domains ([@B39]).                         in *trans* ([@B67]).                                     *Trans* -- NEGR1 ([@B81]). *Cis* -- LAMP ([@B67]). *ECM --* NA.                                                                                                                                                   NA                                                                                                                  -- Promotes ([@B119]).                                                                                            -- Promotes ([@B65]; [@B145]; [@B41]).   NA
  OPCML/IGLON1                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          

  **Thy1**/\          One V-type domain ([@B144]).                            In *trans* ([@B72]).                                     *Trans* -- β3 integrin ([@B64]). *Cis* -- Integrins ([@B60]). *ECM* -- NA.                                                                                                                                        -- Promotes when binds to antibodies ([@B61]; [@B79]; [@B17]); -- Inhibits when binds to αVβ3 integrins ([@B46]).   NA                                                                                                                NA                                       KO: -- LTP in CA1 is normal; -- LTP in dentate gyrus is impaired ([@B151]).
  CD90/CDw90                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

GPI-Anchored IgSF CAMs and Their Homophilic and Heterophilic Interactions
-------------------------------------------------------------------------

Immunoglobulin superfamily CAMs are identified by the presence of immunoglobulin (Ig)-like domains in their ectodomains. There are several types of Ig domains present in IgSF CAMs including C2-, V-, and I-type ([@B143]; [@B40]). The V-type is similar to the variable V-domain in Igs, whereas the C2 type is similar to C1-domains in Igs ([@B5]). The I-type (I for intermediate) shares similarities with C1- and V-type domains and was initially identified in Telokin, an intracellular smooth muscle protein ([@B40]). GPI-anchored IgSF CAMs differ in the numbers of V-, C2-, or I-type Ig domains present in their ectodomains. For example, only one V-type Ig domain is present in Thy-1, while there are three C2-type Ig domains present in neuronal growth regulator 1 (NEGR1), and six C2-type domains present in contactin-1, -2, -3 ([@B114]; [@B143]; [@B10]; [@B155]; **Figure [1](#F1){ref-type="fig"}**). The first four Ig domains of contactin-2 have also been classified as I-type Ig domains in some studies ([@B40]; [@B27]). All Ig domains of the IgSF CAMs have a core of two β-sheets facing each other and stabilized by an intra-chain disulfide bridge ([@B19]; **Figure [2](#F2){ref-type="fig"}**). Ectodomains of IgSF CAMs may also contain fibronectin type III repeats, which are also present in ectodomains of some GPI-anchored IgSF CAMs, such as contactin-1, -2, -3 (**Figures [1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}**).

![Crystal structure of the fragment of contactin-3 containing Ig-like domains 5 and 6 and fibronectin type III domains 1 and 2. **(A)** fibronectin type III (FN) and immunoglobulin-like (Ig) C2-type domains of contactin-3 are shown as a ribbon diagram in two views flipped 90° to demonstrate the β-sheet orientation and disulfide bonds in Ig domains (green lines). β-Sheet strands are shown as light purple arrows in Ig6, FN2, and FN1 and multicolored arrows in Ig5. Coils are in light pink and turns are in light blue. **(B)** A ribbon diagram of the Ig5 domain with one β-sheet represented by strands A (orange), B (red), E (green), and D (purple) and the second sheet represented by strands A′ (yellow), C (cyan), F (blue), and G (pink). Strands E and F are connected by a short helix (in magenta). Two views flipped 90° are shown to demonstrate the β-sheet orientation and the disulfide bond represented as a green line in both views and highlighted by a red box in the upper view. Dashed green line represents the disulfide bond behind the B--C coil. **(C)** A ribbon diagram of the Ig5 domain with β-sheet strands re-colored to demonstrate the two sheets, one comprised of strands A, B, E, and D (red) and another comprised of strands A′, C, F, and G (blue) with the disulfide bond (green) holding the two sheets together. Image of PDB ID 5I99 ([@B89]) created with Protein Workshop ([@B84]).](fnmol-10-00378-g002){#F2}

In the human and murine genomes, genes coding for GPI-anchored IgSF CAMs include *NEGR1, opioid-binding cell adhesion molecule* (*OBCAM*), *neurotrimin* (*Ntm*), *limbic system-associated membrane protein* (*LAMP*), *IgLON5, contactin-1, -2, -3, -4, -5, -6, Thy-1*, and *carcinoembryonic antigen-related cell adhesion molecule* (*CEACAM)-5, -6, -7*, and *-8* ([@B144]; [@B94]; [@B149], [@B148]; [@B39]; [@B93]; [@B30]; [@B51]; [@B118]) (**Table [1](#T1){ref-type="table"}** and **Figure [1](#F1){ref-type="fig"}**). OBCAM, Ntm, LAMP, NEGR1, and IgLON5 constitute the IgLON family ([@B145]; [@B41]; [@B119]). In addition, short isoforms of some transmembrane IgSF CAMs, such as the shortest isoform of the neural cell adhesion molecule (NCAM) with the molecular weight 120 kDa (NCAM120), are also GPI-anchored ([@B44]).

Glycosylphosphatidylinositol-anchoring of proteins to the plasma membranes is a highly conserved post-translational modification across all eukaryotes ([@B28]). The GPI anchor is a complex structure consisting of a phosphoethanolamine linker, glycan core, and phospholipid tail. Structural variations of the anchor are possible by the modification of phosphoinositol, glucosamine, and mannose residues within the glycan core ([@B100]; [@B28]). Application of phosphatidylinositol-specific phospholipase C (PI-PLC), an enzyme capable of cleaving the GPI anchor, induces removal of GPI-anchored IgSF CAMs from the cell surface, indicating that the GPI anchor is critical for the attachment of these proteins to the cellular membranes ([@B119]). The complexity of the GPI anchor, however, suggests that it also plays a role in other multiple functions aside from membrane anchorage, including signal transduction, protein sorting, as well as the structure and function regulation of the GPI-anchored IgSF CAMs. In particular, the GPI anchor links these molecules to membrane microdomains that are insoluble in cold non-ionic detergents ([@B139]; [@B28]). Such specialized membrane microdomains are referred to as lipid rafts and render GPI-anchored proteins resistant to cold non-ionic detergent extraction ([@B121]; [@B124]).

The ectodomains of GPI-anchored IgSF CAMs contain multiple glycosylation sites. For example, IgLON protein family members with three Ig domains contain six or seven *N*-glycosylation sites in their ectodomains (**Figure [1](#F1){ref-type="fig"}**; [@B103]; [@B51]). NCAM120 is a prominent example of a glycosylated GPI-anchored IgSF CAM ([@B150]), because similarly to transmembrane NCAM isoforms it can carry polysialic acid (PSA) ([@B22]).

Multiple subdomains in the extracellular domains of IgSF CAMs have been suggested to contain binding sites for interactions with other Ig domain-containing proteins ([@B11]). Indeed, Ig domains have been shown to play a key role in homophilic and heterophilic *trans-*interactions between IgSF CAMs, i.e., the interaction between two identical IgSF CAMs on membranes of adjacent cells, and the interaction of IgSF CAMs with other proteins in the extracellular environment ([@B115]; [@B141]; [@B59]). In addition to mediating *trans*-interactions, IgSF CAMs bind in *cis*, i.e., laterally, to surface proteins present in the same cell surface plasma membrane ([@B43]). *Cis*-interactions can enhance the *trans*-interactions of IgSF CAMs and are also involved in signal transduction across the membrane ([@B125]; [@B56]). Similarly to transmembrane IgSF CAMs, GPI-anchored IgSF CAMs mediate homo- and heterophilic interactions. For example, LAMP, OBCAM, Ntm, Thy-1, CEACAM5, contactin-2, and NCAM120 bind homophilically *in trans* while CEACAM6 binds heterophilically *in trans* to CEACAM8 ([@B95]; [@B72]; [@B112]; [@B153]; [@B154]; [@B67]; [@B132]; [@B36]). Neurotractin (a chick homolog of human NEGR1) appears to be unique in the IgLON family in that it does not bind homophilically, but heterophilically binds to Ntm and LAMP ([@B76]), although a later study reported that mammalian NEGR1 was able to interact homophilically ([@B81]). GPI-anchored IgSF CAMs also interact in *cis*. For example, LAMP and OBCAM heterophilically interact in *cis* to create dimeric IgLONS (diglons) and formation of this complex changes the ability of both proteins to regulate neuronal development ([@B47]; [@B113]; [@B115]; [@B43]).

GPI-Anchored IgSF CAMs As Functional Receptors
----------------------------------------------

The role for IgSF CAMs as functional receptors has been suggested by studies analyzing effects of antibodies against these molecules on neurite outgrowth. Early studies using antibodies against Thy-1 as a growth substrate showed that Thy-1 antibodies enhance regeneration of neurites in rat retinal ganglion neurons and promote survival of mouse cerebellar Purkinje cells ([@B61]; [@B79]). Similarly, antibodies against Thy-1 promote neurite outgrowth in rat dorsal root ganglion (DRG) neurons when applied in the culture medium ([@B17]). Later, natural ligands of GPI-anchored IgSF CAMs have also been shown to induce neurite outgrowth changes. Retinal ganglion cells from Thy-1 knock-out mice show impaired neurite outgrowth over different substrates made of the proteins of the extracellular matrix, including fibronectin and collagen, and Thy-1 knock-out mice demonstrate abnormal retinal formation with thinner retinae ([@B123]). Thy-1 has also been identified as a receptor for αVβ3 integrin. Binding of integrins to Thy-1 at the neuronal cell surface induces signal transduction across the cell membrane resulting in inactivation of the c-Src protein tyrosine kinase, reduced neurite outgrowth, as well as neurite retraction ([@B46]). In this study, neuron-derived Cath-a-differentiated (CAD) cells grown on a monolayer of DITNC1 astrocyte cells, which expressed αVβ3 and β3 integrins, had inhibited neurite outgrowth compared to CAD cells grown over a monolayer of DITNC1 cells treated with Thy-1-Fc protein, anti-β3 integrin antibodies, or transfected with siRNA against the β3 chain of the integrin. Neurite outgrowth inhibition in CAD cells on a substrate of αVβ3-Fc was abolished by silencing Thy-1 expression by shRNA. Furthermore, while αVβ3-Fc reduced dendritic length in primary cortical neurons, application of PI-PLC to cleave Thy-1 prior to the addition of αVβ3-Fc prevented the inhibition of dendrite outgrowth ([@B46]).

Chondroitin sulfate E has been shown to activate contactin-1 to stimulate neurite outgrowth in primary mouse hippocampal neurons ([@B80]). In addition to being a receptor to chondroitin sulfate E, contactin-1 binds to the second and third fibronectin type III (FNIII)-like domains of tenascin-R. Binding of tenascin-R to contactin-1 promotes neurite outgrowth ([@B90]), and induces formation of filopodia and lamellipodia along neurites ([@B152]). Contactin-1 is also a receptor for the receptor-type protein tyrosine phosphatase zeta (PTPRZ) ([@B101]; [@B8]), and induces neurite outgrowth in chick tectal neurons in response to binding to PTPRZ ([@B101]). Recent work also showed that contactin-1 at the cell surface of hippocampal neurons binds in *trans* to contactin-associated transmembrane receptor 2 (CASPR2) ([@B117]). The physiological role of this interaction remains to be analyzed. The role for contactin-1 as a functional receptor in regulation of neuronal development is also supported by *in vivo* observations in contactin-1 knock-out mice. Granule cells are the major neuron population expressing contactin-1 in axons in the cerebellum. In wild-type mice, the parallel fibers of granule cells extend perpendicular to the dendritic arborizations of Purkinje cells. In contrast, the parallel fibers extend parallel to the plane of Purkinje cell dendritic branches in contactin-1 knock-out mice indicating misguidance of granule cell axon subpopulations ([@B7]).

Contactin-2 has been shown to function as a receptor for neuronal cell adhesion molecule (NrCAM) but not for the neuron--glia cell adhesion molecule (NgCAM) in DRG and sympathetic ganglion neurons ([@B69]). In these neurons, substrate-coated NgCAM and NrCAM, two L1 family CAMs, promote neurite outgrowth. Anti-contactin-2 Fab fragments do not affect the neurite outgrowth induced by NgCAM, but inhibit the NrCAM-dependent neurite outgrowth ([@B69]). Substrate-coated NrCAM and NgCAM interact heterophilically in *trans* with contactin-2 at the cell surface of chick commissural axons and both molecules cooperate in the axonal guidance. However, this interaction is not involved in regulation of the axonal outgrowth ([@B26]). Knock down of contactin-2 with ex-ovo RNAi in the chick embryo affects guidance but not growth of axons of granule cells in the cerebellum ([@B3]). Knock down of contactin-2 results in the failure of granule cells to extend their axons parallel to the pial surface of the cerebellum, creating an uneven molecular layer with decreased parallel fiber density. Since known binding partners of contactin-2, including NgCAM and NrCAM, are not expressed during granule cell axon extension, homophilic interactions of contactin-2 were proposed to be involved in axon guidance in these neurons ([@B3]). Loss of contactin-2 in chick retinal neurons also impairs the ability of retinal neurons to contain their arbors within appropriate sublaminae ([@B146]).

Glycosylphosphatidylinositol-anchored IgSF CAMs can also function as receptors when they are involved in homophilic binding. Cortical neurons grown on a substrate of recombinant OBCAM or LAMP demonstrate a dose-dependent increase in neurite outgrowth ([@B119]). This neurite outgrowth-promoting activity of LAMP has been attributed to the first Ig domain within LAMP mediating homophilic interactions ([@B23]). Homophilic binding of Ntm also induces neurite growth in hippocampal neurons ([@B35], [@B36]).

GPI-Anchored IgSF CAMs As Signal Transducers and Membrane Domain Organizers
---------------------------------------------------------------------------

While GPI-anchored IgSF CAMs do not possess intracellular domains, they induce intracellular signaling and regulate formation of the functional membrane domains by interacting in *cis* with other transmembrane proteins. For example, activation of the intracellular signaling by Thy-1 antibodies is likely to be induced by cross-linking Thy-1 molecules and associated proteins, such as integrins ([@B60]).

Contactin-1 interacts in *cis* with CASPR ([@B102]). The CASPR/contactin-1 complex accumulates in paranodal junctions in myelinated axons during myelination of peripheral nerves ([@B116]). Contactin-1 is necessary to target CASPR to the synaptic membrane, because CASPR is synthesized but not targeted to the cell surface plasma membrane in the hippocampus of contactin-1-deficient mice ([@B116]; [@B85]). Contactin-1 also forms a complex with L1 and Fyn kinase in the mouse cerebellum, suggestive of the capability to transduce signals to intracellular proteins via L1 ([@B96]).

Contactin-2 binds in *cis* to L1. This interaction can be induced by homophilic *trans* interactions of contactin-2 resulting in the *cis* binding to L1 and L1-mediated ankyrin recruitment to the complex ([@B73]). Contactin-2 also binds in *cis* to NgCAM. This heterophilic *cis* interaction promotes neurite outgrowth, whereas heterophilic *trans* interaction between NgCAM and contactin-2 has no effect on neurite outgrowth ([@B12]). Contactin-2 binds directly to the ectodomain of CASPR2 ([@B68]), and both proteins form a *cis* complex but are unable to form a *trans* complex. Despite this, contactin-2 is able to bind homophilically in *trans* to contactin-2 that has formed a *cis* complex with CASPR2 ([@B136]). The physiological significance of this interaction is illustrated by observations in contactin-2 and CASPR2 knock-out mice showing that contactin-2 is necessary for CASPR2 localization at juxtaparanodes in myelinated axons ([@B136]), whereas targeting of contactin-2 to juxtaparanodes depends on CASPR2 and both contactin-2 and CASPR2 are required for accumulation of voltage-gated potassium channels at the juxtaparanodes ([@B105]).

Other contactins also associate in *cis* with various cell surface receptors. For example, contactin-5 forms a *cis* complex with amyloid precursor-like protein 1 (APLP1) on the presynaptic membrane ([@B122]). The second and third Ig domains of contactin-3, -4, -5, and -6 bind to receptor-type protein tyrosine phosphatase G (PTPRG) ([@B8]) and contactin-3 and -6 associate in *cis* with PTPRG at the surface of mouse rod photoreceptor cells ([@B89]). Contactin-6 also interacts *in cis* with the Close Homolog of L1 (CHL1) and binds to and regulates the activity of the receptor-type protein tyrosine phosphatase α (PTPRα) ([@B147]).

Glycosylphosphatidylinositol-anchored IgSF CAMs also interact with the intracellular enzymes and cytoskeleton via lipids. NCAM120 co-localizes and associates with the membrane-cytoskeleton linker protein spectrin in transfected CHO cells and mouse hippocampal neurons, and this association is lost after disruption of the lipid rafts ([@B63]). Overexpression of NCAM120 in cultured hippocampal neurons from NCAM knock-out mice, however, is not sufficient to induce neurite outgrowth in response to recombinant extracellular domain of NCAM ([@B88]). The interaction with spectrin may, however, be important in glial cells where NCAM120 is enriched. Contactin-2 associates with ganglioside GD3 in cerebellar neurons, and clustering of this complex induces activation of the Src family kinase Lyn ([@B54], [@B53]). A recent study showing that NEGR1 interacts with Niemann-Pick disease Type C2 (NPC2) protein and functions in cholesterol transport ([@B55]) suggests that GPI-anchored IgSF CAMs may also be involved in regulation of the lipid composition of the plasma membrane.

GPI-Anchored IgSF CAMs As Functional Ligands
--------------------------------------------

Glycosylphosphatidylinositol-anchored IgSF CAMs also function as ligands for other cell surface receptors in neurons and other cells. Early work on contactin-1 has demonstrated that neurite outgrowth in DRG neurons grown on CHO cells transfected with contactin-1 is increased ([@B32], [@B33]). Further work showed that contactin-1 exerts dual cell-specific effects on neurite outgrowth by inhibiting neurite outgrowth in cerebellar granule cells and stimulating neurite outgrowth in sensory neurons, whereas it does not affect hippocampal neurons ([@B33]; [@B14]), suggesting that contactin-1 activates different receptors expressed by these cells ([@B14]). Among neuronal receptors for contactin-1 are members of the L1 family. NrCAM and NgCAM have been shown to interact heterophilically with contactin-1 ([@B83]). However, despite having shown that contactin-1 interacts with NrCAM and NgCAM, only NrCAM was found to enhance the outgrowth of chick retinal neurons ([@B137]). Tectal cells adhere to and extend neurites on a substrate of contactin-1 and this effect is blocked by the application of Fab fragments against NrCAM but not NgCAM ([@B83]). While these experiments indicate that the interaction between contactin-1 and NrCAM induces neurite outgrowth, receptors mediating the inhibitory effects of contactin-1 on neurite outgrowth and the role that the interaction between contactin-1 and NgCAM plays remain to be determined. Contactin-1 was also identified to be a ligand of Notch in oligodendrocytes being involved in the signaling pathway of oligodendrocyte maturation ([@B48]). The role for contactin-1 as a functional ligand is also supported by *in vivo* observations. Contactin-1 is not detected in dendrites of granule cells ([@B24]). However, development of the dendrites is affected in contactin-1 knock-out mice resulting in a significant reduction of granule cell postsynaptic area ([@B7]), suggesting that contactin-1 expressed on other cells acts as a functional ligand to regulate dendrite formation.

Contactin-2 used as a substrate induces neurite outgrowth in rat and chick DRG neurons ([@B31]; [@B126]) and in rat and mouse cerebellar neurons ([@B53]; [@B142]). Removal of contactin-2 by PI-PLC from DRG neurons cultured on a substrate of contactin-2 does not affect the effect of contactin-2 substrate on neurite outgrowth ([@B25]) indicating that homophilic interactions of contactin-2 are not involved. Contactin-2-dependent neurite outgrowth is blocked by Fab fragments against L1 ([@B58]; [@B126]; [@B25]; [@B142]) and β1 integrin ([@B25]), indicating that L1 and integrins are contactin-2 receptors, which promote neurite outgrowth. Contactin-2 was also shown to be a ligand of amyloid precursor protein (APP). Binding of contactin-2 to APP triggers cleavage of APP resulting in the release of its intracellular domain, which negatively modulates neurogenesis ([@B70]).

Neurite outgrowth in rat hippocampal neurons is enhanced when they are grown on substrate-coated recombinant contactin-3 and -4 ([@B149], [@B148]), or on HEK293 cells transfected with contactin-4, -5, and -6 ([@B8]; [@B78]), indicating that other CAMs of the contactin family can also function as *trans* ligands. Contactin-3 and -6 associate with PTPRG not only in *cis* but also in *trans* when expressed on the surfaces of apposing cells ([@B89]). Hence, PTPRG is likely to be a neuronal receptor for these CAMs of the contactin family. However, contactin-4, -5, and -6 display identical binding to PTPRG but differentially promote neurite outgrowth and branching at distinct developmental stages ([@B78]), suggesting that other receptors are also involved. These receptors remain to be identified in future work.

*Trans*-interactions have also been reported for Thy-1 presented as a ligand. Thy-1 was identified in a neurite outgrowth-promoting complex containing also laminin and a heparin sulfate proteoglycan ([@B38]). Thy-1 expressed at the neuronal cell surface functions as a ligand for αVβ3 integrin at the cell surface of astrocytes ([@B45]). This interaction leads to integrin clustering, tyrosine phosphorylation of focal adhesion kinase (FAK) and p130Cas, activation of RhoA and p160ROCK, recruitment of paxillin, vinculin, and FAK to focal contacts resulting in formation of focal adhesion and stress fibers in rat astrocytes ([@B64]; [@B2], [@B1]).

Cell adhesion molecules of the IgLON family NEGR1 and Ntm are constitutively shed from the cell surface and create a growth permissive substrate. Inhibition of their shedding by a pan-metalloproteinase inhibitor (BB-94) inhibits neurite outgrowth in cortical neurons and IgLON CAMs accumulate at the cell surface, whereas an increase in shedding by PI-PLC promotes neurite outgrowth ([@B119]). A recent report showing that soluble NEGR1 promotes neuronal arborization in FGFR2- and ERK1/2-dependent manner ([@B104]) suggests that FGFR2 is one of the receptors for NEGR1 at the neuronal cell surface. The shedding of IgLON CAMs not only provides a growth permissive substrate but also renders cortical neurons grown on the IgLON substrate insensitive to the growth inhibitory effects of BB-94 suggesting that shed IgLON CAMs mitigate inhibitory signals transduced by a NEGR1- or Ntm-containing complex at the neuronal cell surface ([@B119]).

Another member of IgLON family, LAMP, inhibits the neurite outgrowth in DRG neurons by heterophilically binding to Ntm expressed in these neurons ([@B36]). The second Ig domain of LAMP, which is not involved in homophilic interactions, harbors the outgrowth inhibiting activity ([@B23]). Soluble recombinant Ntm induces neurite outgrowth in DRG neurons. This effect is also observed after removal of Ntm from the cell surface of these neurons by PI-PLC indicating that it is mediated by heterophilic interactions of Ntm. In contrast, Ntm inhibits neurite outgrowth in SCG neurons. These neurons do not express Ntm, and therefore Ntm's effects are also mediated by heterophilic interactions ([@B35], [@B36]).

GPI-Anchored IgSF CAMs Are Present in Synapses in Neurons
---------------------------------------------------------

The presence of multiple GPI-anchored IgSF CAMs in synapses was first suggested by biochemical analysis of synaptic terminals, synaptosomes, isolated from the brain tissue. Early work with Thy-1 antigen showed that Thy-1 was present in synaptosomes isolated from the mouse brain with later work showing that Thy-1 is a component of large dense core and small clear vesicles of PC12 cells which are similar to neuronal synaptic vesicles ([@B128]; [@B52]). Later studies showed the presence of different GPI-anchored IgSF CAMs in synaptosomes, including contactin-1 and contactin-2 ([@B85]; [@B4]).

Immunoelectron microscopic analysis of contactin-1 localization revealed that depending on the type of synapse, contactin-1 is localized to either the pre- or post-synaptic membranes ([@B24]). For example, in the mouse cerebellum contactin-1 is localized pre-synaptically in synapses between parallel fibers of granule cells and dendritic spines of Purkinje cells and in synapses between mossy fiber terminals and granule cell dendrites, and is localized post-synaptically in synapses formed on Golgi cell dendrites ([@B24]). In the hippocampal CA1 region, contactin-1 is distributed at the surface of pyramidal cell dendrites, dendritic spine heads, and post-synaptic densities, and is also present in biochemically isolated post-synaptic density fractions ([@B85]). Contactin-2 has also been shown to localize to synaptic plasma membranes isolated from rat forebrain ([@B4]).

In contrast to contactin-1, Ntm has been shown to accumulate both pre- and post-synaptically in synapses between parallel fibers of granule cells and dendritic spines of Purkinje cells and in synapses between mossy fiber terminals and granule cell dendrites but was not present in inhibitory synapses made by stellate or basket cells ([@B18]). LAMP is expressed pre- and post-synaptically in synapses in the developing lateral septum, but is detected only post-synaptically in synapses formed on granule cells of the dentate gyrus in adult hippocampus ([@B151]).

Electron microscopic immunohistochemistry has demonstrated that NEGR1 is present at high levels in post-synaptic densities and at lower levels pre-synaptically in synapses along dendrites and on somata of neurons in the cerebral cortex and hippocampal CA3 region of adult rats ([@B81]). OBCAM shows similar ultrastructural distribution as NEGR1 with OBCAM immunoreactivity limited to postsynaptic densities of dendritic and somatic synapses in the cerebral cortex and hippocampal CA3 region of adult rats ([@B81]).

Several studies indicate that GPI-anchored IgSF CAMs are also present in synaptic organelles. Biochemical analysis of Thy-1 in the rat brain showed that it is targeted to small synaptic vesicles (SSVs) and large dense core vesicles (LDCVs) ([@B52]). OBCAM is present in neurosecretory granules in neurites of hypothalamic magnocellular neurons ([@B82]). Mass spectrometry analysis of synaptic vesicles also identified NEGR1, OBCAM, Ntm, Thy-1, LAMP, and contactin-1 as components of synaptic vesicles ([@B133]).

Role of the GPI-Anchored IgSF CAMs in Synapse Formation Regulation
------------------------------------------------------------------

Protein expression and localization of the GPI-anchored IgSF CAMs is developmentally regulated. Levels of Thy-1 strongly increase from postnatal day 14, whereas levels of NEGR1, OBCAM, and contactin-1 gradually increase during development and reach the highest level at 4 weeks after birth in the cerebral cortex, diencephalon, hippocampus, and cerebellum ([@B81]). Ntm levels gradually increase in the forebrain during development reaching the plateau at postnatal day 7 and then decline in adults ([@B129]). Ntm levels are also increased in the molecular layer and the internal granular layer of the cerebellum during the period of synaptogenesis and reduce shortly after the active period of synaptogenesis ends, but remain high at synaptic contacts ([@B18]). Levels of NCAM and particularly NCAM120 increase in chick cornea and corneal nerves during corneal innervation ([@B75]). High expression of the GPI-anchored IgSF CAMs at the time of active synaptogenesis and their synaptic localization suggests that they play a role in synapse formation.

The role of the GPI-anchored IgSF CAMs in synapse formation is further indicated by studies showing that disruption of their functions or increase in their levels in neurons affect synaptogenesis. Overexpression of OBCAM in hippocampal neurons increases numbers of synapses along dendrites of transfected neurons ([@B41]), whereas disruption of OBCAM functions using antibodies or by suppressing its expression using the antisense oligodeoxynucleotide results in impaired formation of synapses on dendrites of hippocampal neurons indicating that OBCAM promotes synapse formation ([@B145]). OBCAM expression has been observed to be higher during early postnatal development and it decreases over time suggesting that OBCAM is active in the regulation of synapse formation ([@B65]; [@B145]). An increase in synapse formation has also been observed in cultured hippocampal neurons overexpressing LAMP ([@B41]) and NCAM120 ([@B22]). Interestingly, overexpression of NEGR1 decreases numbers of synapses formed on dendrites of hippocampal neurons ([@B41]). Thus, different GPI-anchored IgSF CAMs not only promote, but can also reduce synaptogenesis.

The molecular mechanisms of synaptogenesis regulation by the GPI-anchored IgSF CAMs remain poorly understood. Interestingly, ablation of NCAM expression in GABAergic basket interneurons in the postnatal mouse cortex results in impaired maturation of perisomatic synapses formed by these neurons, and this phenotype is rescued by NCAM120 ([@B16]). The NCAM120-dependent maturation of synapses is inhibited by a dominant-negative form of Fyn kinase ([@B16]) indicating that GPI-anchored IgSF CAMs regulate synapse formation not only via changes in cell adhesion but also by activating intracellular signaling.

GPI-Anchored IgSF CAMs in Regulation of Synaptic Plasticity
-----------------------------------------------------------

Recent reports indicate that GPI-anchored IgSF CAMs also play a role in synaptic plasticity. Constitutively contactin-1-deficient mice show decreased paired pulse facilitation (PPF). Long-term potentiation (LTP) in the CA1 region of the hippocampus of these mice is normal, whereas long-term depression (LTD) is impaired ([@B85]). In contactin-1 transgenic mice generated to induce overexpression of full-length contactin-1 under control of the human contactin-2 promoter, PPF is not changed at 5 and 12 months of age indicating that the short-term plasticity is not altered by contactin-1 overexpression. However, LTP in the CA1 region of the hippocampus is increased in contactin-1-overexpressing mice at 12 months of age despite no change in LTP in contactin-1 transgenic mice at 5 months of age ([@B109]). Further analysis of LTP in the CA1 region of the hippocampus in older animals showed that LTP is impaired in 24-month-old wild-type mice when compared to 3--5-month-old wild-type animals. However, the age-dependent decline in LTP was slower in mice overexpressing contactin-1. Hence, contactin-1 is likely to play a role in maintaining synaptic plasticity in the adult brain during aging ([@B109], [@B108]). Synaptic transmission is impaired in LAMP knock-out mice with a reduction in LTP in the CA1 region of the hippocampus ([@B110]). LTP in the CA1 region of the hippocampus in Thy-1 knock-out mice was normal although LTP was absent in the dentate gyrus of these mice ([@B91]). These observations indicate that GPI-anchored IgSF CAMs are involved in regulation of the different forms of synaptic plasticity in brain region-dependent manner.

GPI-Anchored IgSF CAMs in Regulation of Learning and Behavior
-------------------------------------------------------------

Glycosylphosphatidylinositol-anchored IgSF CAMs are also involved in regulation of learning and behavior. Thy-1 knock-out mice have been found to fail in observing social cues to select food that had been socially cued ([@B77]). It was therefore proposed that the loss of Thy-1 while not fatal is still under evolutionary pressure as the inability to select cued (and therefore safe) food would quickly push for the conservation of Thy-1. Spatial learning as assessed by the Morris water maze test was not affected in Thy-1 knock-out mice ([@B91]).

Mice deficient for LAMP exhibit heightened reactivity to novelty, lower anxiety, and lower sensitivity to stressful environment ([@B15]; [@B49], [@B50]). LAMP deficiency in mice also results in impaired spatial learning as indicated by increased time LAMP-deficient mice need to locate the underwater platform in the Morris water maze ([@B110]). The role for LAMP in regulation of behavior is further suggested by observations showing that LAMP expression levels are increased in the hippocampus of mice exposed to the enriched environment ([@B42]).

The link between changes in contactin-1 expression and age-dependent learning impairments has been demonstrated in studies showing that the age-dependent decline in contactin-1 levels in wild-type mice correlates with a higher latency in finding the hidden platform in the Morris water maze ([@B97]; [@B108]). The age-dependent increase in the time required to find the hidden platform in the Morris water maze is reduced in transgenic contactin-1-overexpressing mice ([@B108]). Furthermore, while old wild-type mice spend equal amounts of time exploring the novel and familiar objects in the novel object recognition test analyzing recognition memory, the old contactin-1-overexpressing mice spend more time exploring the novel object ([@B108]).

GPI-Anchored IgSF CAMs in Brain Disorders
-----------------------------------------

Several observations indicate that contactin-2 may play a role in the onset of epilepsy. A homozygous single base pair deletion (c.503_503delG) of contactin-2 was identified to be present in individuals affected with autosomal recessive cortical myoclonic tremor and epilepsy in a consanguineous Egyptian family ([@B127]). The role of contactin-2 in epilepsy is further suggested by studies in mice showing that while gross brain morphology of contactin-2 null mice appears to be indistinguishable from their wild-type littermates, contactin-2 null mice display spontaneous episodes of seizures despite demonstrating normal behavior and are more sensitive to convulsant stimuli than their wild-type littermates ([@B29]).

Genome-wide analysis of copy number variations in autism spectrum disorder (ASD) patients identified a trend for the contactin gene family (*contactin-4, -5, -6*) to be associated with ASD ([@B138]; [@B87]; [@B107]). The identification of multiple contactin CAMs in ASD has led to the suggestion that genetic interactions between contactins are involved in different degrees of ASD ([@B107]).

Autoantibodies against contactin-1 were shown to be present in a subset of patients suffering from chronic inflammatory demyelinating polyneuropathy (CIDP) ([@B111]), suggesting that contactin-1 is involved in neuromyopathies. Chronic passive transfer of anti-contactin-1 IgG4 in Lewis rats results in progressive motor deterioration ([@B74]), indicating that antibodies against contactin-1 are pathogenic in CIDP. A study on a consanguineous family with a homozygous contactin-1 mutation presenting with lethal congenital myopathy also supports the role contactin-1 may have in peripheral neuromyopathies ([@B21]).

Increased levels of NCAM120 were found in the cerebrospinal fluid (CSF) of patients suffering from bipolar disorder and depression suggesting that NCAM120 may be involved in mood disorders ([@B106]).

Patient case studies found that deletions of 1p31.1 to 1p31.3 containing the *NEGR1* gene present with developmental co-ordination disorder, attention deficit/hyperactivity disorder, learning disability, as well as delayed speech and language development ([@B37]; [@B135]). A genome-wide copy number scan identified *NEGR1* to be one of five new candidate genes involved in dyslexia ([@B140]). A case study on two siblings with interstitial microdeletion of 1p31.1 involving only *NEGR1* presented with learning and behavioral problems, hypotonia, hypermobility, scoliosis, and aortic root dilation ([@B34]). Further suggestive of the role NEGR1 has in brain disorders, NEGR1 is also elevated in the CSF of bipolar and depressed patients ([@B71]). In Dark Agouti rats, NEGR1 is upregulated in response to venlafaxine (VLX), a serotonin and noradrenaline reuptake inhibitor used to treat major depressive disorder (MDD), suggesting that NEGR1 contributes to the VLX effect in MDD possibly by contributing to the establishment of new neuronal connections and changes in synaptic plasticity ([@B134]).

A study on male contemplated suicide identified LAMP SNPs to be associated with suicide ([@B86]). However, it is important to note that after multiple correction tests the association did not maintain statistical significance leading the authors to suggest that LAMP may play a role in suicidal behavior but more work is required to confirm their initial findings. Genotyping showed that four SNPs (rs1461131, rs4831089, rs16824691, and rs9874470) of LAMP were significantly associated with MDD ([@B57]). In addition, LAMP expression was significantly increased in the dorsolateral prefrontal cortex of schizophrenic and bipolar disorder patients ([@B6]).

In a study on late-onset Alzheimer's disease, four SNPs (rs1629316, rs1547897, rs11222931, and rs11222932) in intron 1 of the Ntm gene (11q25) and one SNP (rs11223225) in intron 1 of the OBCAM gene (located on the same chromosome as Ntm \< 80 kb apart) have been found to be associated with late-onset Alzheimer's disease ([@B66]). Genome-linkage studies in two independent Dutch populations indicate that depression is also associated with a locus on chromosome 11q25 suggesting a link to OBCAM ([@B120]). In a study of schizophrenia in Thai populations, four SNPs (rs3016384, rs1784519, rs1894193, and rs1939498) of OBCAM have been identified to be linked to schizophrenia ([@B99]). An earlier study also identified OBCAM to be implicated in schizophrenia; however, the association was nominally significant ([@B92]). Genome-wide analysis of aggressiveness in attention deficit hyperactivity disorder (ADHD) found that one of two significant loci associated with aggressiveness in ADHD was within the Ntm gene ([@B9]). Additionally, Ntm has also been identified to be associated with intelligence as demonstrated by a family-based association study ([@B98]).

Conclusion and Future Directions
--------------------------------

Glycosylphosphatidylinositol-anchored IgSF CAMs play important roles in regulation of neuronal development, synapse formation and function, learning, and behavior. Previous research indicates that in addition to mediating adhesive interactions, these molecules induce intracellular signaling by binding to other cell surface receptors, regulating their levels and functions, and assembling membrane microdomains.

Further research is, however, needed to characterize the whole repertoire of the interactions of GPI-anchored IgSF CAMs in developing and mature neurons, and in synapses to fully understand the role these molecules play in the developing and mature nervous system and molecular mechanisms involved. While several neurite outgrowth-promoting receptors for GPI-anchored IgSF CAMs have been described, observations showing that even relatively well-characterized contactin-1 not only promotes but also inhibits neurite outgrowth in a neuron-specific manner suggest that there are still other receptors that remain to be identified. How the repertoire of molecular interactions involving GPI-anchored IgSF CAMs changes during neuronal development remains also poorly understood. The roles that these interactions play in regulating synapse formation and function are mostly unknown. It is possible that GPI-anchored IgSF CAMs promote synapse formation by forming homophilic adhesive bonds connecting pre- and post-synaptic membranes. However, these molecules are often asymmetrically expressed in synapses and are found either pre- or post-synaptically. This observation suggests that GPI-anchored IgSF CAMs regulate synapse formation by heterophilically interacting with other receptors or CAMs in synaptic membranes. Further characterization of the synaptic interactions of GPI-anchored IgSF CAMs is necessary to understand molecular mechanisms activated by these molecules during synapse formation. It may also help to understand the role that GPI-anchored IgSF CAMs play in synaptic plasticity suggested by abnormalities in mice with altered expression of these molecules, and to characterize the signaling pathways regulated by GPI-anchored IgSF CAMs in synapses.

Further analysis of the post-translational modifications of GPI-anchored IgSF CAMs is necessary to understand mechanisms of the regulation of the functions of these molecules. Shedding of the IgLON family members was shown to play an important role during neuronal development. The role that proteolysis of GPI-anchored IgSF CAMs plays in regulation of synapse numbers and remodeling during synaptic plasticity remains to be investigated. Regulation of the homophilic and heterophilic interactions of GPI-anchored IgSF CAMs by glycosylation of the multiple sites within their ectodomains is also an intriguing possibility, which remains to be analyzed. Whether GPI anchor-mediated interactions with lipids play a role in the transport of GPI-anchored IgSF CAMs, their sorting to lipid rafts, microdomain assembly, and signal transduction also remains to be investigated.

Genetic association studies in humans have started to illuminate the role of GPI-anchored IgSF CAMs in brain disorders. Biochemical analyses of the changes in levels and synaptic targeting of GPI-anchored IgSF CAMs in postmortem human brain tissue and in animal models are necessary to corroborate these findings and may reveal yet unknown roles of these molecules in brain disorders. Future research analyzing molecular mechanisms of GPI-anchored IgSF CAM function and regulation will help to understand the molecular mechanisms of brain disorders linked to abnormal expression or function of these molecules, and may pave the way for development of new treatments of these disorders.
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